headlinez.news Live news trend intelligence

Q2 2026 Earnings

16 independently checked trend briefs about this subject, newest first.

What this Q2 2026 Earnings timeline shows

headlinez.news detected 16 source-qualified news clusters connected to Q2 2026 Earnings between June 25, 2026 and July 29, 2026. They span 1 newsroom category and average 8.1 independent sources per brief.

This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.

◼ Archived Business 🔮 fades ✓

Corning Q2 2026 earnings beat but stock falls on guidance

Major technology and retail stocks face significant market volatility as earnings beats are countered by underwhelming future revenue and profit guidance.

11 sources 21 articles v 17 12d ago
◼ Archived Business 🔮 fades ✓

SK Hynix second-quarter profit surges 557% to a new high

SK Hynix reported a record-breaking 557% profit surge, yet the results failed to meet market expectations, sparking concerns about the AI memory boom.

6 sources 6 articles v 18 13d ago
◼ Archived Business 🔮 fades ✓

The new Air Force One just got a big update

Boeing’s Air Force One replacement program incurs a $280 million charge, complicating the company's financial results despite record airplane deliveries.

9 sources 9 articles v 7 13d ago
◼ Archived Business 🔮 fades ✓

Hasbro Reports Second Quarter 2026 Financial Results

Hasbro and Intel post contrasting quarterly financial results as shifting market sentiment impacts stock performance across the gaming and technology sectors.

13 sources 15 articles v 14 17d ago
◼ Archived Business 🔮 fades ✗

Johnson & Johnson CFO Says Guidance Hike Is Just the Start

Johnson & Johnson shares dipped despite an earnings beat and raised guidance as investors weigh strong medicine sales against medical technology underperformance.

10 sources 10 articles v 8 25d ago